In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SJM’s Endosense Deal Highlights Growing Importance Of Contact Force Technology In AF Ablation

Executive Summary

St. Jude Medical has acquired Swiss company Endosense, a pioneer in the field of contact force sensing for atrial fibrillation ablation. The $170 million plus milestones deal will enable St. Jude to compete more effectively against market leader Biosense Webster/J&J, but it also emphasizes the growing importance of contact force technology in the AF ablation space.

Advertisement

Related Content

AF Ablation Procedures Driving CRM Market Expansion
Use The Force: St. Jude Hopes To Build AFib Footprint With Pressure-Sensing Catheter
St. Jude First To Market Leadless Pacemaker With Nanostim Buy
VC Funding In 2013: Some Impressive Device Rounds, But Momentum Shifts To Biotech
New Paradigms Brewing In Atrial Fibrillation Ablation
St. Jude Gains Force-Sensing Catheter Technology With Endosense Acquisition
Bard EP Deal Latest In Boston Scientific’s M&A Revival, Bolsters CRM Business
At HRS, Topera Topples Conventional Wisdom About Atrial Fibrillation
Device Companies Follow New Map To Atrial Fibrillation
Endosense: Facing Technology and Financing Challenges in AF

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel